# Identification of antimicrobial peptides from ancient gut microbiomes

**Authors:** Sizhe Chen, Yue Yuan, Yun Wang, Ye Peng, Hein Min Tun, Zhimin Jiang, Yinglei Miao, Sunjae Lee, Xiaole Yin, Xiaotao Shen, Orlando DeLeon, Eugene B. Chang, Francis Ka Leung Chan, Yang Sun, Siew Chien Ng, Qi Su

PMC · DOI: 10.1038/s41467-026-68495-0 · Nature Communications · 2026-01-14

## TL;DR

The paper introduces a new tool to find antimicrobial peptides in ancient human gut samples, revealing that a once-common gut bacterium may hold effective antimicrobial properties.

## Contribution

The development of AMPLiT, a portable and efficient tool for identifying antimicrobial peptides in metagenomic data.

## Key findings

- 160 AMP candidates were identified from seven ancient human coprolite metagenomes.
- 36 out of 40 synthesized peptides showed measurable antimicrobial activity in vitro.
- S. copri-derived AMPs demonstrated potent antibacterial and wound-healing efficacy in vivo.

## Abstract

Fecal coprolites preserve ancient microbiomes and are a potential source of extinct but highly efficacious antimicrobial peptides (AMPs). Here, we develop AMPLiT (AMP Lightweight Identification Tool), an efficient tool deployable to portable hardware for AMP screening in metagenomic datasets. AMPLiT demonstrates AUPRC performances of 0.9486 ± 0.0003 and reasonable overall training time of 3200 ± 53 s. By computationally utilizing AMPLiT, we analyze seven ancient human coprolite metagenomes, identifying 160 AMP candidates. Of 40 representative peptides synthesized, 36 (90%) peptides demonstrate measurable antimicrobial activity at 100 μM or less in vitro. Strikingly, approximately two-thirds of these peptides are sourced from Segatella copri, a dominant ancient gut commensal that is conspicuously underrepresented in modern populations, particularly those with Westernized lifestyles. Representative S. copri-derived AMPs exhibit disruptions against membranes of pathogenic bacteria, coupled with low cytotoxicity and hemolytic risk. In vivo, lead peptides demonstrate potent antibacterial and wound-healing efficacy comparable to traditional antibiotics, especially in combating gram-positive pathogens. Our findings highlight the ancient gut microbiomes as sources of novel AMPs, offering valuable insights into the historical role of S. copri in human health and its decline in contemporary populations.

Here, the authors develop AMPLiT a tool for screening antimicrobial peptides in metagenomic datasets, and apply it to human coprolite metagenomes, finding that Segatella copri, an ancient prevalent human gut bacterium declined in modern populations, harbors unexplored antimicrobial reservoir, offering an alternative approach against modern pathogenic infections.

## Linked entities

- **Species:** Segatella copri (taxon 165179)

## Full-text entities

- **Diseases:** hemolytic (MESH:D006461), cytotoxicity (MESH:D064420)
- **Chemicals:** AMP (MESH:D000089882)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917264/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917264/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917264/full.md

---
Source: https://tomesphere.com/paper/PMC12917264